Source: International Congress 2015 – Sarcoidosis: pathogenesis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Caroline Broos (Rotterdam, Netherlands), Caroline Broos, Menno Van Nimwegen, Hans In ’t Veen, Jouke Annema, Roxane Heller, Henk Hoogsteden, Rudi Hendriks, Bernt Van den Blink, Mirjam Kool. Specific activation of non-classical Th1 cells in pulmonary sarcoidosis. Eur Respir J 2015; 46: Suppl. 59, 3314

Member's Comments

No comment yet.

Related content which might interest you: iNKT cells are inversely related to β-glucan in BALF and granuloma formation in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Circulating monocytes from interstitial lung disease patients show an activated phenotype Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Anti-parietal cell autoimmunity in IPF patients Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Role of dendritic cells in pulmonary fibrosis in mice Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Treg depletion reduces bleomycin-induced pulmonary fibrosis by inducing Th17 and other CD4+T cell subset responses in lung Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Imbalance of M1/M2 alveolar macrophages phenotype in pulmonary sarcodosis Source: Annual Congress 2013 –Sarcoidosis Year: 2013 A mechanism for acceleration of GM-CSF autoantibody (GMAb) production in autoimmune pulmonary alveolar proteinosis (aPAP) Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014 Modulation of lung CD11c+ dendritic cells by TGF-β in pulmonary fibrosis in mice Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 Differential bronchoalveolar expression of candidate microRNAs in chronic obstructive pulmonary disease, asthma bronchiale and pulmonary sarcoidosis Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014 Loss of PTEN induced lung fibroblasts exhibiting similar pathogenic features to cancer cells in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Phenotypically aberrant and clonal T cell in the lung of patients with refractory coeliac disease Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 B-cell infiltration varies among patients with interstitial lung diseases Source: International Congress 2016 – ILD pathogenesis Year: 2016 IL-17+ cells immunoexpression in systemic sclerosis pulmonary fibrosis Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Variation in mortality from interstitial lung disease by diagnosis Source: International Congress 2015 – IIPs: orphan Year: 2015 HCMV infection triggers the development of interstitial lung diseases in autoimmune disorders Source: International Congress 2014 – IPF and surroundings Year: 2014 B-lymphocyte targeted therapy for patients with progressive fibrosing mediastinitis Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 Inhibition of profibrotic signaling in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF) by histone deacetylase-inhibitors (HDACi) or the IPF drug pirfenidone Source: International Congress 2014 – ILDs 1 Year: 2014 Does apoptosis evasion only affect fibroblasts from idiopathic pulmonary fibrosis? Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013